The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: a conceptual model for COVID-19
From MaRDI portal
(Redirected from Publication:2137459)
Recommendations
- Multiscale models of COVID-19 with mutations and variants
- Evaluating the impacts of relaxation and mutation in the SARS-CoV-2 on the COVID-19 epidemic based on a mathematical model: a case study of São Paulo state (Brazil)
- Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants
- Coupling compartmental models with Markov chains and measure evolution equations to capture virus mutability
- A multi-strain model with asymptomatic transmission: application to COVID-19 in the US
Cites work
Cited in
(9)- Variant-specific interventions to slow down replacement and prevent outbreaks
- Antiviral resistance against viral mutation: praxis and policy for SARS-CoV-2
- Adaptive behaviors and vaccination on curbing COVID-19 transmission: modeling simulations in eight countries
- scientific article; zbMATH DE number 7653033 (Why is no real title available?)
- Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants
- Modeling mutation-driven emergence of drug-resistance: a case study of SARS-CoV-2
- Advanced models for COVID-19 variant dynamics and pandemic waves
- Multi-age group epidemic model with social contacts
- Stability and bifurcation in an age-structured predator-prey system with Beddington-Deangelis response, constant prey harvesting, and two delays
This page was built for publication: The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: a conceptual model for COVID-19
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2137459)